CDC: Surveillance for AIDS-Defining Opportunistic Illnesses, 1992-1997
Table 3
From U.S. Centers for Disease Control and Prevention
April 19, 1999
TABLE 3. Percentage* of persons with at least one acquired immunodeficiency syndrome-defining opportunistic illness (OI)for whom a given OI occurred first, by disease and year of diagnosis -- Adult/Adolescent Spectrum of HIV Disease project,+ 1992-1997 |
| Disease |
Total
(N=12,982) |
1992
(N=3,023) |
1993
(N=2,804) |
1994
(N=2,648) |
1995
(N=2,107) |
1996
(N=1,602) |
1997
(N=798) |
Trend&
|
Pneumocystis carinii
pneumonia |
35.9 |
36.6 |
35.0 |
34.7 |
34.7 |
38.1 |
42.6 |
none |
| Esophageal candidiasis |
12.4 |
11.5 |
11.4 |
11.2 |
14.1 |
14.8 |
15.0 |
increasing |
| Kaposi sarcoma |
11.6 |
11.1 |
12.0 |
11.6 |
13.2 |
9.5 |
10.7 |
none |
| Wasting syndrome |
7.8 |
10.5 |
6.1 |
5.8 |
7.2 |
8.4 |
12.2 |
increasing |
| Mycobacterium avium complex |
6.4 |
5.7 |
5.7 |
8.2 |
7.2 |
5.6 |
4.8 |
decreasing |
| Pulmonary tuberculosis |
5.0 |
6.4 |
5.9 |
5.2 |
3.7 |
2.6 |
3.6 |
decreasing |
| Extrapulmonary cryptococcosis |
4.3 |
4.0 |
5.0 |
3.8 |
4.6 |
4.3 |
3.8 |
none |
| HIV encephalopathy |
4.2 |
3.8 |
4.7 |
4.1 |
3.5 |
5.1 |
3.6 |
none |
| Cytomegalovirus retinitis |
3.7 |
3.4 |
3.8 |
4.3 |
3.5 |
4.0 |
2.6 |
none |
| Cytomegalovirus disease |
3.2 |
3.7 |
2.7 |
3.1 |
4.0 |
3.3 |
1.1 |
none |
| Toxoplasmosis of brain |
3.0 |
2.9 |
3.0 |
3.0 |
3.1 |
3.3 |
2.6 |
none |
| Chronic cryptosporidiosis |
2.7 |
1.8 |
3.2 |
3.2 |
3.1 |
2.8 |
1.5 |
none |
| Recurrent pneumonia |
2.5 |
2.1 |
2.7 |
2.5 |
2.5 |
2.8 |
3.0 |
none |
| Extrapulmonary tuberculosis |
2.1 |
2.6 |
2.4 |
2.0 |
1.8 |
1.2 |
0.9 |
decreasing |
| Chronic herpes simplex |
2.1 |
2.4 |
3.1 |
1.7 |
1.8 |
1.3 |
0.5 |
decreasing |
| Immunoblastic lymphoma |
1.5 |
1.2 |
1.4 |
2.3 |
0.8 |
2.1 |
1.9 |
increasing |
Progressive multifocal
leukoencephalopathy |
1.0 |
0.5 |
0.7 |
1.5 |
1.3 |
1.6 |
0.7 |
increasing |
| Invasive cervical cancer@
|
0.9 |
1.1 |
0.5 |
1.5 |
1.1 |
0.1 |
0.9 |
none |
| Disseminated histoplasmosis |
0.7 |
0.9 |
0.7 |
0.7 |
0.7 |
0.3 |
1.0 |
none |
| Burkitts lymphoma |
0.7 |
0.6 |
0.7 |
0.7 |
0.4 |
0.9 |
1.5 |
none |
Other disseminated
Mycobacterium |
0.6 |
1.2 |
0.6 |
0.4 |
0.3 |
0.5 |
0.4 |
decreasing |
| Primary brain lymphoma |
0.4 |
0.6 |
0.3 |
0.6 |
0.3 |
0.3 |
0.1 |
none |
| Pulmonary candidiasis |
0.3 |
0.2 |
0.6 |
0.4 |
0.2 |
0.2 |
0.2 |
none |
| Disseminated coccidioidomycosis |
0.1 |
0.0 |
0.1 |
0.0 |
0.0 |
0.4 |
0.7 |
increasing |
Recurrent Salmonella
septicemia |
0.1 |
0.1 |
0.1 |
0.1 |
0.0 |
0.2 |
0.0 |
none |
| Chronic isosporiasis |
0.0 |
0.0 |
0.1 |
0.0 |
0.0 |
0.0 |
0.1 |
none |
|
* Data for each opportunistic illness are standardized to national acquired immunodeficiency syndrome surveillance cases by age, race, year of diagnosis, country of birth, sex, and human immunodeficiency virus (HIV) exposure mode. Data from all cities are weighted equally.
+ A CDC-sponsored surveillance project that collects data at selected sites in 11 U.S. cities.
Advertisement& -- The direction of change is given for trends that were significant (p<S0.05) based on the stratified (HIV exposure mode, race, sex, age, metropolitan area, and country of birth) Cochran-Mantel-Haenszel statistic.
@ -- Restricted to women.
|
|
|
Advertisement
|
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication Morbidity and Mortality Weekly Report.
Email
Print-Friendly
Glossary
